IMUX
Immunic Inc.
$0.91
+$0.06(+7.55%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$83.36M
Volume
1.88M
52W Range
$0.56 - $1.89
Target Price
$7.47
Order:
Income Statement
| Metric | Trend | Chart | 2014 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-835.0K | $-933.0K | $-999.0K | -- | -- | -- | -- | -- | -- | -- | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $835.0K | $933.0K | $999.0K | -- | -- | -- | -- | -- | -- | -- | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-50.3M | $-41.3M | $-52.7M | $-12.0M | $37.0M | $49.0M | $91.7M | $86.5M | $99.2M | $98.1M | ||
| Research & Development | $39.5M | $30.0M | $39.3M | $9.6M | $22.5M | $38.6M | $61.1M | $71.3M | $83.2M | $80.0M | ||
| Research Expense | $39.5M | $30.0M | $39.3M | $9.6M | $22.5M | $38.6M | $61.1M | $71.3M | $83.2M | $80.0M | ||
| Selling, General & Administrative | $10.9M | $11.2M | $13.3M | $2.4M | $14.5M | $10.3M | $13.3M | $15.3M | $16.0M | $18.0M | ||
| General & Administrative Expenses | $10.9M | $11.2M | $13.3M | $2.4M | $14.5M | $10.3M | $13.3M | $15.3M | $16.0M | $18.0M | ||
| Salaries & Wages | $-2.5M | $-4.7M | $-5.5M | $-3.7M | $-6.5M | $2.7M | $5.9M | $7.9M | $7.1M | $8.5M | ||
| Depreciation & Amortization | $-1.1M | $-1.8M | $-1.0M | $-15.0K | $-50.0K | $39.0K | $85.0K | $77.0K | $111.0K | $134.0K | ||
| Depreciation & Amortization | $-1.1M | $-1.8M | $-1.0M | $-15.0K | $-50.0K | $39.0K | $85.0K | $77.0K | $111.0K | $134.0K | ||
| Amortization | -- | -- | -- | -- | -- | $33.0M | $33.0M | -- | -- | -- | ||
| Securities Amortization | $4.7M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Operating Expenses | $-50.3M | $-41.3M | $-52.7M | $-12.0M | $-37.0M | $49.0M | $-17.3M | -- | $99.2M | $98.1M | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-50.3M | $-41.3M | $-52.7M | $-12.0M | $-37.0M | $-49.0M | $-91.7M | $-119.5M | $-99.2M | $-98.1M | ||
| EBITDA | $-51.3M | $-39.2M | $-51.1M | $-11.5M | $-34.9M | $-48.9M | $-91.6M | $-86.4M | $-93.5M | $-100.4M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Intinc | $2.6M | $284.0K | $650.0K | $521.0K | $107.0K | $58.0K | $66.0K | $1.0M | $3.1M | $3.4M | ||
| Net Non-Operating Interest Income/Expense | $2.6M | $284.0K | $650.0K | $521.0K | $107.0K | $58.0K | $66.0K | $1.0M | $3.1M | $3.4M | ||
| Other Income/Expense | $-56.0K | $-13.0K | $73.0K | $-455.0K | $-2.0M | $-4.9M | $1.3M | $-34.9M | $-2.5M | $1.0M | ||
| Other Special Charges | $56.0K | $13.0K | $-73.0K | $455.0K | $2.0M | $4.9M | $-1.3M | $-2.0M | $2.5M | $-1.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | $53.0M | $19.3M | -- | -- | -- | -- | -- | ||
| Special Income Charges | -- | -- | -- | $-53.0M | $-19.3M | -- | -- | $-33.0M | -- | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | -- | -- | $33.0M | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-52.4M | $-41.0M | $-52.1M | $-11.5M | $-34.9M | $-49.0M | $-91.7M | $-86.5M | $-93.6M | $-100.5M | ||
| Pre-Tax Income | $-52.4M | $-41.0M | $-52.1M | $-11.5M | $-34.9M | $-44.0M | $-58.4M | $-120.4M | $-93.6M | $-95.7M | ||
| NET INCOME | ||||||||||||
| Net Income | $-52.4M | $-41.0M | $-52.1M | $-41.5M | $-34.9M | $-44.0M | $-92.9M | $-120.4M | $-93.6M | $-100.5M | ||
| Net Income (Continuing Operations) | $-52.4M | $-41.0M | $-52.1M | $-41.5M | $-34.9M | $-44.0M | $-92.9M | $-120.4M | $-93.6M | $-100.5M | ||
| Net Income (Discontinued Operations) | $-52.4M | $-41.0M | $-52.1M | $-41.5M | $-34.9M | $-44.0M | $-92.9M | $-120.4M | $-93.6M | $-100.5M | ||
| Net Income (Common Stockholders) | $-56.8M | $-41.0M | $-52.1M | $-11.5M | $-34.9M | $-44.0M | $-92.9M | $-120.4M | $-93.6M | $-100.5M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-46.2M | -- | -- | $-94.8M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-51.2M | $-42.2M | $52.7M | $-12.0M | $37.0M | $49.0M | $91.7M | $86.5M | $99.2M | $98.1M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $401.4K | $784.7K | $996.5K | $1.1M | $7.7M | $15.7M | $23.7M | $31.8M | $44.3M | $100.2M | ||
| Average Shares Outstanding (Diluted) | $370.1K | $781.9K | $993.9K | $1.1M | $7.7M | $15.7M | $23.7M | $31.8M | $44.3M | $100.2M | ||
| Shares Outstanding | $599.8K | $803.6K | $1.1M | $1.1M | $10.7M | $21.2M | $27.9M | $44.4M | $89.9M | $90.2M | ||
| Basic EPS | -- | -- | -- | -- | -- | $-2.81 | $-3.93 | $-3.78 | $-2.11 | $-1 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-2.81 | $-3.93 | $-3.78 | $-2.11 | $-1 | ||
| Diluted EPS | $-141.6 | $-52.4 | $-52.4 | $-39.2 | $-4.52 | $-2.81 | $-3.93 | $-3.78 | $-2.11 | $-1 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $-4.52 | -- | $-3.93 | $-3.78 | $-2.11 | $-1 | ||
| OTHER METRICS | ||||||||||||
| Accretion On Preferred Stock | $4.4M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $10.9M | $11.2M | $13.3M | $2.4M | $14.5M | $10.3M | $13.3M | $15.3M | $16.0M | $18.0M | ||
| Other Impairment Of Capital Assets | -- | -- | -- | $1.2M | -- | -- | -- | -- | -- | -- | ||
| Otherunder Preferred Stock Dividend | $4.4M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $4.4M | -- | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $10.9M | $11.2M | $13.3M | $2.4M | -- | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | $53.0M | $19.3M | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMUX | $0.91 | +7.6% | 1.88M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |